"Missão Promover Saúde através de Atendimento Médico Hospitalar qualificado em Oncologia, de forma Humanizada, em Âmbito Nacional, para pacientes do Sistema Único de Saúde, apoiado em Programas de Prevenção, Ensino e Pesquisa. Visão Ser Reconhecido a Nível Nacional e Internacional pela Excelência na Prestação de Serviços, com Ênfase na Humanização ao Paciente do Sistema Único de Saúde em Prevenção, Diagnóstico, Tratamento, Ensino e Pesquisa em Oncologia. Comprometido com a Expansão e Ações Padronizadas apoiadas em Gestão da Qualidade no Atendimento em Território Nacional gerando Novas Políticas e Diretrizes em Oncologia. Valores Amor Humanização Honestidade Humildade Ética Respeito Comprometimento Trabalho em Equipe"

During the past decade, Hospital de Cancer de Barretos conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 17 clinical trials were completed, i.e. on average, 37.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 11 clinical trials were completed. i.e. 68.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Cancer de Barretos" #1 sponsor was "Barretos Cancer Hospital" with 24 trials, followed by "Hoffmann-La Roche" with 18 trials sponsored, "M.D. Anderson Cancer Center" with 3 trials sponsored, "Latin American Cooperative Oncology Group" with 2 trials sponsored and "Spectrum Pharmaceuticals, Inc" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Cancer de Barretos" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "M.D. Anderson Cancer Center" with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Fundação de Amparo à Pesquisa do Estado de São Paulo" with 2 trials as a collaborator and "University of Campinas, Brazil" with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Cancer de Barretos" are "Breast Cancer" (7 trials), "Cervical Cancer" (4 trials), "Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Cervical Intraepithelial Neoplasia" (2 trials). Many other conditions were trialed in "Hospital de Cancer de Barretos" in a lesser frequency.

Most popular intervention types in "Hospital de Cancer de Barretos" are "Drug" (42 trials), "Procedure" (16 trials), "Other" (9 trials), "Device" (7 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Paclitaxel" (6 trials), "Placebo" (6 trials), "Bevacizumab" (4 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Cancer de Barretos" are 47 trials for "All" genders, 22 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Cancer de Barretos". undefined are not yet recruiting, 13 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Hospital de Cancer de Barretos, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Cancer de Barretos, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".

Hospital de Cancer de Barretos has several departments that took part in Clinical trials: "FUNDACAO PIO XII Hospital de Cancer de Barretos" - 56 trials, "Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica" - 2 trials